Charles Schwab Investment Management Inc Verrica Pharmaceuticals Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 99,505 shares of VRCA stock, worth $791,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
99,505
Previous 43,653
127.95%
Holding current value
$791,064
Previous $347,000
127.95%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VRCA
# of Institutions
73Shares Held
20.3MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY8.57MShares$68.1 Million1.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY2.81MShares$22.3 Million0.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.36MShares$18.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$8.1 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...